Product Reports Resources Pricing Login Book a demo

Northstar Nuclear Medicine

Biotech & Life Sciences · Madison, United States · Founded 2006

Providing patients global access to game-changing radiopharmaceuticals MoreLess

NorthStar Medical Radioisotopes is a pioneering company in the field of diagnostic and therapeutic radiopharmaceuticals. They develop innovative products and technologies that are shaping the future of this industry. Their primary market is the healthcare sector, where they supply stable, reliable, and environmentally-friendly radioisotopes for patient care and clinical research.

The company's business model revolves around the production and distribution of these radioisotopes. They source these materials domestically, ensuring a consistent supply chain that meets the critical needs of their clients, which include hospitals, research institutions, and pharmaceutical companies.

NorthStar Medical Radioisotopes has a strong track record and is recognized as an emerging global leader in the field of radiopharmaceuticals. They have a vision for the future and are committed to advancing radioisotope technology to shape a better world.

The company has also been involved in several strategic partnerships and agreements. For instance, they have a long-term supply agreement with Curadh MTR for the therapeutic radioisotope Actinium-225 (Ac-225). They have also executed a supply agreement with Bayer for the same radioisotope.

In addition, the company is actively involved in clinical trials. They recently announced that the first participant has been treated using their Electron Accelerator-produced Copper-67 (Cu-67) in a Phase I/IIa Theranostic Clinical Trial for the treatment of Neuroblastoma.

Keywords: Radiopharmaceuticals, Healthcare, Radioisotopes, Clinical Research, Supply Chain, Global Leader, Strategic Partnerships, Therapeutic Radioisotope, Clinical Trials, Neuroblastoma Treatment.

Company overview

Northstar Nuclear Medicine company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2006
Headquarters
Madison, United States
Employees
315
Open positions
17
Dealroom signal
71.7
client focusb2bsub industryPharmaceuticalsub industryMedical DevicesindustryHealthsectorRisk ManagementsectorBiotechnologysectorOncologysectorCardiology and cardiovascularsectorHealth DiagnosticssectorBiotech and PharmasectorRadioisotope TherapeuticssectorHard TechsectorRadiopharmaceuticalssectorDT and LS

Valuation & funding

Northstar Nuclear Medicine funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing Aug 2021 $37M National Nuclear Security Administration
EARLY VCOther financing Apr 2019 $75M $300M Oberland Capital
EARLY VCOther financing Sep 2015 $270K $1.1M Stateline Angels
EARLY VCOther financing Sep 2012 $5.2M $21M Illinois Ventures · Stateline Angels
Showing 4 recorded eventsUnlock the complete deal history →

Growth signals

Northstar Nuclear Medicine website traffic

Latest recorded traffic for Northstar Nuclear Medicine is 2.9K monthly website visits, down 31% over the last three months. Northstar Nuclear Medicine's team grew 3.3% over the past year.

Latest monthly visits2.9K 3-month web change-31% 1-year team growth+3.3%
Monthly website visits119 observations · Apr 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Northstar Nuclear Medicine compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Northstar Nuclear Medicine's talent

Book a demo to see the people
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

4 investors on Northstar Nuclear Medicine's cap table

Sourced from Dealroom's funding and investor records.

Seed 1 investor entered at this stage
National Nuclear Security Administration
Series A 3 investors entered at this stage
Illinois Ventures
Stateline Angels
Oberland Capital

Global footprint

Where Northstar Nuclear Medicine has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about Northstar Nuclear Medicine

Recent press, funding announcements, and product moves mentioning Northstar Nuclear Medicine — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Northstar Nuclear Medicine

An AI-synthesized read of the highest-engagement posts about Northstar Nuclear Medicine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Northstar Nuclear Medicine’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.